(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
-0.57% $ 7.04
@ $9.40
Wydano: 14 vas. 2024 @ 20:07
Zwrot: -25.11%
Poprzedni sygnał: vas. 14 - 18:58
Poprzedni sygnał:
Zwrot: 1.68 %
Live Chart Being Loaded With Signals
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications...
Stats | |
---|---|
Dzisiejszy wolumen | 1.14M |
Średni wolumen | 1.24M |
Kapitalizacja rynkowa | 923.50M |
EPS | $0 ( 2024-05-02 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.52 |
ATR14 | $0.0110 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-29 | Rahmer Peter | Sell | 1 345 | Common Stock |
2024-04-29 | Adams Brian | Sell | 1 623 | Common Stock |
2024-04-29 | Catinazzo Thomas | Sell | 1 695 | Common Stock |
2024-04-29 | Bergstrom Donald A | Sell | 2 686 | Common Stock |
2024-03-27 | Catinazzo Thomas | Sell | 348 | Common Stock |
INSIDER POWER |
---|
88.11 |
Last 99 transactions |
Buy: 4 152 455 | Sell: 364 261 |
Wolumen Korelacja
Relay Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
TXG | 0.941 |
NEOG | 0.926 |
GLPG | 0.926 |
AMPH | 0.925 |
MAXN | 0.923 |
DCFC | 0.92 |
BGFV | 0.917 |
BIRD | 0.914 |
NVTS | 0.913 |
PRTS | 0.911 |
10 Najbardziej negatywne korelacje | |
---|---|
GRCL | -0.916 |
MSAC | -0.902 |
IVCB | -0.899 |
FTGC | -0.899 |
GGAL | -0.898 |
TZPS | -0.897 |
TRMR | -0.891 |
GHRS | -0.889 |
RETA | -0.889 |
AEYE | -0.887 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Relay Therapeutics, Inc. Korelacja - Waluta/Towar
Relay Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $25.55M |
Zysk brutto: | $20.28M (79.37 %) |
EPS: | $-2.79 |
FY | 2023 |
Przychody: | $25.55M |
Zysk brutto: | $20.28M (79.37 %) |
EPS: | $-2.79 |
FY | 2022 |
Przychody: | $1.38M |
Zysk brutto: | $-2.75M (-199.06 %) |
EPS: | $-2.27 |
FY | 2021 |
Przychody: | $3.03M |
Zysk brutto: | $3.03M (100.00 %) |
EPS: | $-3.93 |
Financial Reports:
No articles found.
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for patients with advanced or metastatic FGFR2-altered solid tumors; RLY-2608, a lead mutant-PI3Ka inhibitor program that targets phosphoinostide 3 kinase alpha; and RLY-1971, an oral small molecule inhibitor of protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2 that is in Phase 1 trial in patients with advanced solid tumors. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; and Genentech, Inc. for the development and commercialization of RLY-1971. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej